Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer.
Valentina DanesiOriana NanniFlavia FocaAngelo DelmonteLucio CrinòGiuseppe BronteMaria RagonesiRoberta MaltoniSilvia ManuntaPaola CraveroKalliopi AndrikouIlaria PrianoWilliam BalziNicola GentiliThomas BurkeMattia AltiniPublished in: Cancers (2022)
Even if a small proportion of patients received a 1L IO, the data showed an improved survival outcomes in the Post-1L IO group.